INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2014
|
Net Assets |
£191m |
|
Net Assets per share |
351p |
|
Share price |
290p |
|
Total value of unquoted investments |
£18m |
|
Total number of portfolio companies |
90 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
9.6 |
|
Biogen |
7.7 |
|
Alexion |
7.6 |
|
Celgene |
7.0 |
|
Amgen |
6.1 |
|
Vertex |
5.0 |
|
Illumina |
3.9 |
|
Mylan |
3.6 |
|
Biomarin |
3.2 |
|
Chimerix |
2.9 |
|
|
----------- |
|
Total |
56.6 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
63 |
|
Turning Profitable 2015 |
9 |
|
Unprofitable |
28 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
88 |
|
Europe & UK |
12 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
29 AUGUST 2014